- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03426696
Psychological Status and Related Factors of Thyroid Related Eye Disease
May 21, 2020 updated by: Huijing Ye
The purpose of this study is to evaluate the psychological status of Thyroid Related Eye Disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to evaluate the psychological status of patients of Thyroid Related Eye Disease over 16 years old, and to analyze the related factors of them.
Study Type
Observational
Enrollment (Actual)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510000
- Sun Yat-sen University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
patients in Sun Yat-sen University that diagnosed as Thyroid Related Eye Disease
Description
Inclusion Criteria:
- over 16 years old
- diagnosed as Thyroid Related Eye Disease
Exclusion Criteria:
- any uncontrolled clinical problems
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Thyroid Related Eye Disease
Survey about the psychological condition would done with the patients of Thyroid Related Eye Disease
|
Graves ́ ophthalmopathy quality of life questionnaire, Symptom checklist 90(SLC-90), Hamilton anxiety scale(HAMA), Somatic self-rating scale(SSS), MATRICS Consensus Cognitive Battery (MCCB), Hamilton depression scale(HAMD)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life questionnaire of patients of Thyroid Related Eye Disease
Time Frame: immediately
|
Graves ́ ophthalmopathy quality of life questionnaire (GO-QoL) , The GO-QoL contains 8 questions on visual functioning and 8 questions on appearance; answers on each subscale are transformed to scores ranging from 0 (worst) to 100 (best).
|
immediately
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Symptom checklist 90(SLC-90)
Time Frame: immediately
|
It consists of 90 items yielding nine scores along primary symptom dimensions and three scores among global distress indices.
The primary symptom dimensions that are assessed are somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, and a category of "additional items" which helps clinicians assess other aspect of the clients symptoms.
Positive standard includes: total score 160 points or more, or positive items > 43 points, or any item > 2 points.
|
immediately
|
Hamilton anxiety scale(HAMA)
Time Frame: immediately
|
This scale includes 14 items.
All projects rated as: asymptomatic, light, medium, heavy, or very heavy.
If the total score more than 29 points, there could be severe anxiety; more than 21 points, affirmation have obvious anxiety; more than 14 points, there must be some anxious; more than 7 points might be anxious; if less than 6 points, patients without anxiety symptoms.
|
immediately
|
Somatic self-rating scale(SSS)
Time Frame: immediately
|
Somatic self-rating scale can let the doctor fully understand patients' mood and somatization symptoms.
If the selected items scores more than 30 points, the patient may need to clinic treatment.
|
immediately
|
Hamilton depression scale(HAMD)
Time Frame: immediately
|
It is the most common depression clinical application scale.
Lower score presents lighter condition, and if the illness is heavier, the higher is the score.
There is no depression symptoms for score less than eight points.
|
immediately
|
Young manic rating scale(YMRS)
Time Frame: immediately
|
The Young Mania Rating Scale (YMRS) is a diagnostic questionnaire commonly used to evaluate manic symptoms in patients with bipolar 1 disorder and to assess treatment efficacy in clinical trials.
This rating scale comprises eleven items (elevated mood, increased motor activity - energy, sexual interest, sleep, irritability, speech - rate and amount, language-thought disorder, content, disruptive-aggressive behavior, appearance, and insight).
The total YMRS score is calculated as the summation of each of the eleven individual item scores.Lower score presents lighter condition, and if the illness is heavier, the higher is the score.There is no manic symptoms for score less than five points.
|
immediately
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Huijing Ye, Master, Sun Yat-sen University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2017
Primary Completion (Actual)
December 1, 2018
Study Completion (Actual)
December 31, 2018
Study Registration Dates
First Submitted
February 1, 2018
First Submitted That Met QC Criteria
February 7, 2018
First Posted (Actual)
February 8, 2018
Study Record Updates
Last Update Posted (Actual)
May 21, 2020
Last Update Submitted That Met QC Criteria
May 21, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201701
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroid Related Eye Disease
-
Neothetics, IncCompletedThyroid-Related Eye DiseaseAustralia, New Zealand
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingThyroid Eye Disease, TEDChina
-
Harbour BioMed (Guangzhou) Co. Ltd.RecruitingThyroid OphthalmopathyChina
-
Horizon Therapeutics USA, Inc.CompletedThyroid Eye Disease | Chronic (Inactive) Thyroid Eye DiseaseUnited States
-
Horizon Pharma USA, Inc.Recruiting
-
Assiut UniversityNot yet recruiting
-
Immunovant Sciences GmbHRecruitingThyroid Eye DiseaseUnited States, Belgium, Latvia, Hungary, Spain, Slovakia, Puerto Rico, New Zealand, Turkey
-
Iran University of Medical SciencesWithdrawnThyroid Eye DiseaseIran, Islamic Republic of
-
University of California, Los AngelesTerminatedThyroid Eye DiseaseUnited States
-
University of PittsburghTerminatedThyroid Eye DiseaseUnited States
Clinical Trials on psychological condition
-
University of Colorado, BoulderNational Institute of Mental Health (NIMH)CompletedPhysical Activity | Affect
-
Universidade Federal de Sao CarlosCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.CompletedShoulder Impingement SyndromeBrazil
-
Rutgers, The State University of New JerseyRecruitingAggression | Problem Behavior | Self InjuryUnited States
-
University of MichiganCompleted
-
Columbia UniversityCompletedChronic Lung Disease | Cardiopulmonary DiseaseUnited States
-
Weill Medical College of Cornell UniversityNational Institute on Aging (NIA); Florida Institute for Human and Machine...CompletedPhysical Activity | Aging | Social IsolationUnited States
-
University of LausanneEmpa - Swiss Federal Laboratories for Materials Testing and Research, ZürichCompleted
-
University of California, IrvineCompleted
-
Nanyang Technological UniversityNational Museum of SingaporeUnknownLoneliness | Intergenerational Relations | Well AgingSingapore